已发表论文

中药通过靶向肠道菌群调节脑缺血再灌注损伤的新见解:综述

 

Authors Ren Y, Chen G, Hong Y, Wang Q, Lan B, Huang Z

Received 12 October 2024

Accepted for publication 21 December 2024

Published 10 January 2025 Volume 2025:19 Pages 185—200

DOI https://doi.org/10.2147/DDDT.S500505

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Yan Zhu

Yisong Ren, Gang Chen, Ying Hong, Qianying Wang, Bo Lan, Zhaozhao Huang

Department of Critical Care Medicine, Chengdu Pidu District Hospital of Traditional Chinese Medicine, Chengdu, Sichuan Province, 611731, People’s Republic of China

Correspondence: Zhaozhao Huang, Department of Critical Care Medicine, Chengdu Pidu District Hospital of Traditional Chinese Medicine, No. 169, Zhongxin Avenue, Pidu District, Chengdu, Sichuan Province, 611731, People’s Republic of China, Email tcmhzz@126.com

Abstract: Cerebral ischemia-reperfusion injury (CIRI) is clinically characterized by high rates of morbidity, disability, mortality, and recurrence as well as high economic burden. The clinical manifestations of CIRI are often accompanied by gastrointestinal symptoms such as intestinal bacterial dysbiosis and gastrointestinal bleeding. Gut microbiota plays an important role in the pathogenesis of CIRI, and its potential biological effects have received extensive attention. The gut microbiota not only affects intestinal barrier function but also regulates gastrointestinal immunity and host homeostasis. Traditional Chinese medicine (TCM), a multi-component and multi-targeted drug, has shown remarkable effects and few adverse reactions in the prevention and treatment of CIRI. Notably, the effect of TCM on CIRI by regulating gut microbiota and maintaining gastrointestinal homeostasis has gradually become a hot topic. This review summarizes the functional role of the gut microbiota in the development and progression of CIRI and the therapeutic effects of TCM on CIRI by improving gut microbiota dysbiosis, affecting gut microbiota metabolism, and maintaining host immunity. The active ingredients of TCM used for the treatment of CIRI in relevant studies were saponins, triterpenoids, phenolics, and alkaloids. In addition, the clinical effects of TCM used to treat CIRI were briefly discussed. This review established the clinical significance and development prospects of TCM-based CIRI treatments and provided the necessary theoretical support for the further development of TCM resources for the treatment of CIRI.

Keywords: cerebral ischemia-reperfusion injury, ischemic stroke, gut-brain axis, gut microbiota, traditional Chinese medicine